These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Factors Associated With Successful Withdrawal of Biologic Agents in Children With Colchicine-Resistant Familial Mediterranean Fever. Taş Ö, Aydın F, Sezer M, Çelikel Acar B, Bahçeci O, Çakar N, Dumlupınar E, Özçakar ZB. J Clin Rheumatol; 2024 Oct 01; 30(7):257-263. PubMed ID: 39226611 [Abstract] [Full Text] [Related]
15. Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial. Koga T, Sato S, Miyamoto J, Hagimori N, Kawazoe Y, Arinaga K, Fukushima C, Yamamoto H, Kawakami A. Trials; 2018 Dec 29; 19(1):715. PubMed ID: 30594222 [Abstract] [Full Text] [Related]